Details for New Drug Application (NDA): 021852
✉ Email this page to a colleague
The generic ingredient in TACLONEX is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
Summary for 021852
Tradename: | TACLONEX |
Applicant: | Leo Pharma As |
Ingredient: | betamethasone dipropionate; calcipotriene |
Patents: | 0 |
Suppliers and Packaging for NDA: 021852
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TACLONEX | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 021852 | NDA AUTHORIZED GENERIC | Prasco Laboratories | 66993-938 | 66993-938-61 | 1 TUBE in 1 CARTON (66993-938-61) / 60 g in 1 TUBE |
TACLONEX | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 021852 | NDA AUTHORIZED GENERIC | Prasco Laboratories | 66993-938 | 66993-938-65 | 1 TUBE in 1 CARTON (66993-938-65) / 100 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.064%;0.005% | ||||
Approval Date: | Jan 9, 2006 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021852
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 021852-001 | Jan 9, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 021852-001 | Jan 9, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 021852-001 | Jan 9, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 021852-001 | Jan 9, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription